請用此 Handle URI 來引用此文件：
http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/44547完整後設資料紀錄
| DC 欄位 | 值 | 語言 |
|---|---|---|
| dc.contributor.advisor | 陳秀男(Shiu-Nan Chen) | |
| dc.contributor.author | Yeh-Fang Hu | en |
| dc.contributor.author | 胡鄴方 | zh_TW |
| dc.date.accessioned | 2021-06-15T03:04:20Z | - |
| dc.date.available | 2011-07-31 | |
| dc.date.copyright | 2009-07-31 | |
| dc.date.issued | 2009 | |
| dc.date.submitted | 2009-07-30 | |
| dc.identifier.citation | 文詩雅 (2008). 菇蕈多醣體之細胞免疫提升作用之研究. 國立台灣大學院漁業科學研究所碩士論文.
吳政翰 (2004). β-葡聚多醣體對小白鼠吞噬細胞之吞噬作用和細胞素之影響. 國立台灣大學動物學研究所碩士論文. 吳銘鴻 (2006). 菇蕈高分子多醣體對小鼠的免疫反應及移植腫瘤細胞之影響. 國立台灣大學漁業科學研究所碩士論文. 吳聲華 (2000). 台灣前在食用真菌培養彩色圖鑑. 財團法人食品工業發展. 林欣穎 (2002). 裂褶多醣體的濃度分析及其對小白鼠之抗氧化活性測試. 國立台灣大學動物學研究所碩士論文. 徐聿 (2006). 靈芝、樟芝、裂褶菌多醣體對大白鼠自然殺手細胞與細胞素的影響. 國立台灣大學漁業科學研究所碩士論文. 陳秀男 (2004). 全方位菇蕈多醣體~瞄準你的健康~. 上宏茂研發中心. 2-45 陳健棋 (2000). 食用菇類在醫藥上的應用. 食品工業月刊 32, 54-66. 蘇茂森 (1995). 白蝦養殖產業技術發展與創新. 行政院農委會. 1-204 Akira, S., Takeda, K., and Kaisho, T. (2001). Toll-like receptors: critical proteins linking innate and acquired immunity. Nature Immunology 2, 675-680. Bao, X. F., Zhen, Y., Ruan, L., and Fang, J. N. (2002). Purification, characterization, and modification of T lymphocyte-stimulating polysaccharide from spores of Ganoderma lucidum. Chemical & Pharmaceutical Bulletin 50, 623-629. Barnes, P. F., Abrams, J. S., Lu, S. Z., Sieling, P. A., Rea, T. H., and Modlin, R. L. (1993). Patterns of Cytokine Production by Mycobacterium-Reactive Human T-Cell Clones. Infection and Immunity 61, 197-203. Barry, M., and Bleackley, R. C. (2002). Cytotoxic T lymphocytes: all roads lead to death. Nature Reviews Immunology 2, 401-409. Belardelli, F., and Ferrantini, M. (2002). Cytokines as a link between innate and adaptive antitumor immunity. Trends in Immunology 23, 201-208. Biron, C. A., and Brossay, L. (2001). NK cells and NKT cells in innate defense against viral infections. Current Opinion in Immunology 13, 458-464. Blattman, J. N., and Greenberg, P. D. (2004). Cancer immunotherapy: A treatment for the masses. Science 305, 200-205. Boon, T., and Old, L. J. (1997). Tumor antigens. Current Opinion in Immunology 9, 681-683. Borchers, A. T., Stern, J. S., Hackman, R. M., Keen, C. L., and Gershwin, M. E. (1999). Mushrooms, tumors, and immunity. Proceedings of the Society for Experimental Biology and Medicine 221, 281-293. Borowitz, Baner K. D., Duque R.E., Horton A.F., Marti G., Muirhead K.A., Peiper S. and Rickman W. (1998 ). Clinical applications of flow cytometry: Quality assurance and immunophenotyping of lymphocytes. Approved Guideline. Brekhman, I. I., and Fulder, S. (1980). Man and biologically active substances : the effect of drugs, diet, and pollution on health. Pergamon Press, Oxford ; New York. Burgaleta, C., Territo, M. C., Quan, S. G., and Golde, D. W. (1978). Glucan-activated macrophages - functional characteristics and surface morphology. Journal of the Reticuloendothelial Society 23, 195-204. Burnet, M. (1957a). Cancer - a Biological Approach .1. The Processes of Control. British Medical Journal 1, 779-786. Burnet, M. (1957b). Cancer - a Biological Approach .3. Viruses Associated with Neoplastic Conditions. British Medical Journal 1, 841-846. Cerottini, B. (1974). Cell-mediated cytotoxicity, Allograft rejection, and Tumor immunity. Advances Immunology 18, 67-123. Chang, C. F., Su, M. S., Chen, H. Y., and Liao, I. C. (2003). Dietary beta-1,3-glucan effectively improves immunity and survival of Penaeus monodon challenged with white spot syndrome virus. Fish & Shellfish Immunology 15, 297-310. Chang, S. T. (1996). Mushroom nutriceuticals. World J. Microbiology Biotech 12, 473-476. Chouaib, S., AsselinPaturel, C., MamiChouaib, F., Caignard, A., and Blay, J. Y. (1997). The host-tumor immune conflict: from immunosuppression to resistance and destruction. Immunology Today 18, 493-497. Cikes, M., Friberg, S., and Klein, G. (1973). Progressive Loss of H-2 Antigens with Concomitant Increase of cell-surface antigen(S) determined by moloney leukemia-virus in cultured murine lymphomas. Journal of the National Cancer Institute 50, 347-362. Dalton, D. K., Pitts-Meek, S., Keshav, S., Figari, I. S., Bradley, A., and Stewart, T. A. (1993). Multiple defects of immune cell function in mice with disrupted interferon-gamma genes. Science 259, 1739-1742. Diefenbach, A., and Raulet, D. H. (2002). The innate immune response to tumors and its role in the induction of T-cell immunity. Immunological Reviews 188, 9-21. Dunn, G. P., Bruce, A. T., Ikeda, H., Old, L. J., and Schreiber, R. D. (2002). Cancer immunoediting: from immunosurveillance to tumor escape. Nature Immunology 3, 991-998. Dunn, G. P., Old, L. J., and Schreiber, R. D. (2004). The three Es of cancer immunoediting. Annual Review of Immunology 22, 329-360. Fossati, G., Colnaghi, M. I., Dellapor.G, Cascinel.N, and Veronesi, U. (1971). Cellular and Humoral Immunity against Human Malignant Melanoma. International Journal of Cancer 8, 344-&. Frucht, D. M., Fukao, T., Bogdan, C., Schindler, H., O'Shea, J. J., and Koyasu, S. (2001). IFN-gamma production by antigen-presenting cells: mechanisms emerge. Trends Immunology 22, 556-560. Goodsell, D. S. (2006). The molecular perspective: Tumor necrosis factor. Oncologist 11, 83-84. Harada, T., Miura, N. N., Adachi, Y., Nakajima, M., Yadomae, T., and Ohno, N. (2003). Antibody to soluble 1,3/1,6-beta-D-glucan, SCG in sera of naive DBA/2 mice. Biological & Pharmaceutical Bulletin 26, 1225-1228. Higashijima, J., Shimada, M., Chikakiyo, M., Miyatani, T., Yoshikawa, K., Nishioka, M., Iwata, T., and Kurita, N. (2009). Effect of splenectomy on antitumor immune system in mice. Anticancer Research 29, 385-393. Hoshi, H., Yagi, Y., Iijima, H., Matsunaga, K., Ishihara, Y., and Yasuhara, T. (2005). Isolation and characterization of a novel immunomodulatory alpha-glucan-protein complex from the mycelium of Tricholoma matsutake in basidiomycetes. Journal of Agricultural and Food Chemistry 53, 8948-8956. Ikekawa, T. (1995). Enokitake, flammulina velutipes - host-mediated antitumor polysaccharides. Food Reviews International 11, 203-206. Ikekawa, T., and Ikeda, Y. (1982). Anti-tumor activity of 13-methyl-berberrubine derivatives. Journal of Pharmacobio-Dynamics 5, 469-474. Ikekawa, T., Uehara, N., Maeda, Y., Nakanish.M, and Fukuoka, F. (1969). Antitumor activity of aqueous extracts of edible mushrooms. Cancer Research 29, 734-&. Itoh, H., Ito, H., Amano, H., and Noda, H. (1994). Inhibitory-Action of a (1→6)-Beta-D-Glucan-Protein Complex (F-Iii-2-B) Isolated from Agaricus-Blazei Murill (Himematsutake) on Meth-a Fibrosarcoma-Bearing Mice and Its Antitumor Mechanism. Japanese Journal of Pharmacology 66, 265-271. Janeway, Walport S. (2005). Immunobiology : the immune system in health and disease. Garland Science, New York. Jong, S. C., and Birmingham, J. M. (1992). Medicinal benefits of the mushroom ganoderma. Advances in Applied Microbiology 37, 101-134. Kaneno, R., Fontanari, L. M., Santos, S. A., Di Stasi, L. C., Rodrigues, E., and Eira, A. F. (2004). Effects of extracts from Brazilian sun-mushroom (Agaricus blazei) on the NK activity and lymphoproliferative responsiveness of Ehrlich tumor-bearing mice. Food and Chemical Toxicology 42, 909-916. Kaufman, H. L., and Disis, M. L. (2004). Immune system versus tumor: shifting the balance in favor of DCs and effective immunity. Journal Clinical Investion 113, 664-667. Kiessling, R., Petranyi, G., Karre, K., Jondal, M., Tracey, D., and Wigzell, H. (1976). Killer cells: a functional comparison between natural, immune T-cell and antibody-dependent in vitro systems. Journal of Experimental Medicine 143, 772-780. Kikumoto, S., Miyajima, T., Kimura, K., Okubo, S., and Komatsu, N. (1971). Polysaccharide produced by Schizophyllum-Commune .2. chemical structure of an extracellular polysaccharide. Journal of the Agricultural Chemical Society of Japan 45, 162-&. Kim, H. M., Han, S. B., Oh, G. T., Kim, Y. H., Hong, D. H., Hong, N. D., and Yoo, I. D. (1996). Stimulation of humoral and cell mediated immunity by polysaccharide from mushroom Phellinus linteus. International Journal of Immunopharmacology 18, 295-303. Kobayashi, M., Fitz, L., Ryan, M., Hewick, R. M., Clark, S. C., Chan, S., Loudon, R., Sherman, F., Perussia, B., and Trinchieri, G. (1989). Identification and Purification of Natural-Killer Cell Stimulatory Factor (Nksf), a Cytokine with Multiple Biologic Effects on Human-Lymphocytes. Journal of Experimental Medicine 170, 827-845. Komatsu, N., Okubo, S., Kikumoto, S., Kimura, K., Saito, G., and Sakai, S. (1969). Host-mediated antitumor action of schizophyllan a glucan produced by Schizophyllum Commune. Gann 60, 137-&. Kong, L. K., Nam SY, Hong HD (1991). Experimental studies on activity of the cultivated mycelia of Phellinus linteus. Korea Journal Pharmacogn 22, 233-239. Ladanyi, A., Timar, J., and Lapis, K. (1993). Effect of lentinan on macrophage cytotoxicity against metastatic tumor-cells. Cancer Immunology Immunotherapy 36, 123-126. Layton, J. E., Shimamoto, G., Osslund, T., Hammacher, A., Smith, D. K., Treutlein, H. R., and Boone, T. (1999). Interaction of granulocyte colony-stimulating factor (G-CSF) with its receptor - evidence that Glu(19) of G-CSF interacts with Arg(288) of the receptor. Journal of Biological Chemistry 274, 17445-17451. Lee, M. S. (2002). Cytokine Synergism in apoptosis: Its role in diabetes and cancer. Journal of Biochemistry and Molecular Biology 35, 54-60. Leung, M. Y. K., Liu, C., Koon, J. C. M., and Fung, K. P. (2006). Polysaccharide biological response modifiers. Immunology Letters 105, 101-114. Liang, J. S., Melican, D., Cafro, L., Palace, G., Fisette, L., Armstrong, R., and Patchen, M. L. (1998). Enhanced clearance of a multiple antibiotic resistant Staphylococcus aureus in rats treated with PGG-glucan is associated with increased leukocyte counts and increased neutrophil oxidative burst activity. International Journal of Immunopharmacology 20, 595-614. Liu, J. J., Huang, T. S., Hsu, M. L., Chen, C. C., Lin, W. S., Lu, F. J., and Chang, W. H. (2004). Antitumor effects of the partially purified polysaccharides from Antrodia camphorata and the mechanism of its action. Toxicology and Applied Pharmacology 201, 186-193. Liu, Y. J., Zhang, J., Lane, P. J., Chan, E. Y., and MacLennan, I. C. (1991). Sites of specific B cell activation in primary and secondary responses to T cell-dependent and T cell-independent antigens. Europen Journal Immunology 21, 2951-2962. Luci, C., and Tomasello, E. (2008). Natural killer cells: Detectors of stress. International Journal of Biochemistry & Cell Biology 40, 2335-2340. Marchessault, R. H., Deslandes, Y., Ogawa, K., and Sundararajan, P. R. (1977). X-Ray-diffraction data for beta-(1→3)-D-glucan. Canadian Journal of Chemistry-Revue Canadienne De Chimie 55, 300-303. Mattner, F., Fischer, S., Guckes, S., Jin, S. C., Kaulen, H., Schmitt, E., Rude, E., and Germann, T. (1993). The interleukin-12 subunit P40 specifically inhibits effects of the interleukin-12 heterodimer. European Journal of Immunology 23, 2202-2208. Mitchell, M. S. (1988). Combining chemotherapy with biological response modifiers in treatment of cancer. Journal of the National Cancer Institute 80, 1445-1450. Miura, T., Miura, N. N., Ohno, N., Adachi, Y., Shimada, S., and Yadomae, T. (2000). Failure in antitumor activity by overdose of an immunomodulating beta-glucan preparation, Sonifilan. Biological & Pharmaceutical Bulletin 23, 249-253. Mizuno, T., Yeohlui, P., Kinoshita, T., Zhuang, C., Ito, H., and Mayuzumi, Y. (1996). Antitumor activity and chemical modification of polysaccharides from niohshimeji mushroom, Tricholma giganteum. Bioscience Biotechnology and Biochemistry 60, 30-33. Moradali, M. F., Mostafavi, H., Ghods, S., and Hedjaroude, G. A. (2007). Immunomodulating and anticancer agents in the realm of macromycetes fungi (macrofungi). International Immunopharmacology 7, 701-724. Mosmann, T. (1983). Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. Journal Immunology Methods 65, 55-63. Nanba, H., and Kubo, K. (1997). Effect of Maitake D-fraction on cancer prevention. Cancer 833, 204-207. Pelizon, A. C., Kaneno, R., Soares, A. M. V. C., Meira, D. A., and Sartori, A. (2005). Immunomodulatory activities associated with beta-glucan derived from Saccharomyces cerevisiae. Physiological Research 54, 557-564. Plat, J., and Mensink, R. P. (2005). Food components and immune function. Current Opinion in Lipidology 16, 31-37. Robinson, B. W., McLemore, T. L., and Crystal, R. G. (1985). Gamma interferon is spontaneously released by alveolar macrophages and lung T lymphocytes in patients with pulmonary sarcoidosis. Journal Clincinal Investigation 75, 1488-1495. Roitt, I. M., Brostoff, J., and Male, D. K. (2001). Immunology. 5th edition Mosby, Edinburgh ; New York. Roitt, I. M., Hutchings, P. R., Dawe, K. I., Sumar, N., Bodman, K. B., and Cooke, A. (1992). The Forces Driving Autoimmune-Disease. Journal of Autoimmunity 5, 11-26. Ross, G. D., and Vetvicka, V. (1993). Cr3 (Cd11b, Cd18) - a Phagocyte and Nk cell-membrane receptor with multiple ligand specificities and functions. Clinical and Experimental Immunology 92, 181-184. Ruizherrera, J. (1991). Biosynthesis of beta-glucans in fungi. Antonie Van Leeuwenhoek International Journal of General and Molecular Microbiology 60, 73-81. Rus, H., Cudrici, C., and Niculescu, F. (2005). The role of the complement system in innate immunity. Immunologic Research 33, 103-112. Sajeevan, T. P., Philip, R., and Singh, I. S. B. (2009). Dose/frequency: A critical factor in the administration of glucan as immunostimulant to Indian white shrimp Fenneropenaeus indicus. Aquaculture 287, 248-252. Schauens.E, and Hoflerbe.E (1972). Cytospectrometric determination of succinodehydrogenase activity in isolated cells with Mtt reagent. Monatshefte Fur Chemie 103, 1271-&. Sharon, N., and Lis, H. (1993). Carbohydrates in cell recognition. Scientific American 268, 82-89. Shiratori, Y., Kawase, T., Nakata, R., Tanaka, M., Hikiba, Y., Okano, K., Matsumura, M., Niwa, Y., Komatsu, Y., Shiina, S., and et al. (1995). Effect of splenectomy on hepatic metastasis of colon carcinoma and natural killer activity in the liver. Digestive Disease and Science 40, 2398-2406. Smyth, M. J., Cretney, E., Kershaw, M. H., and Hayakawa, Y. (2004). Cytokines in cancer immunity and immunotherapy. Immunological Reviews 202, 275-293. Smyth, M. J., Crowe, N. Y., Hayakawa, Y., Takeda, K., Yagita, H., and Godfrey, D. I. (2002). NKT cells - conductors of tumor immunity? Current Opinion in Immunology 14, 165-171. Sonoda, K., Izumi, K., Matsui, Y., Inomata, M., Shiraishi, N., and Kitano, S. (2006). Decreased growth rate of lung metastatic lesions after splenectomy in mice. European Surgical Research 38, 469-475. Suzuki, I., Hashimoto, K., Ohno, N., Tanaka, H., and Yadomae, T. (1989). Immunomodulation by orally-administered beta-glucan in mice. International Journal of Immunopharmacology 11, 761-769. Takimoto, F., Wakita, D., Kawaguchi, K., and Kumazawa, Y. (2004). Potentiation of cytotoxic activity in naive and tumor-bearing mice by oral administration of hot-water extracts from Agaricus brazei fruiting bodies. Biological & Pharmaceutical Bulletin 27, 404-406. Talmadge, J. E., Meyers, K. M., Prieur, D. J., and Starkey, J. R. (1980). Role of Nk cells in tumor-growth and metastasis in beige mice. Nature 284, 622-624. Thornton, B. P., Vetvicka, V., Pitman, M., Goldman, R. C., and Ross, G. D. (1996). Analysis of the sugar specificity and molecular location of the beta-glucan-binding lectin site of complement receptor type 3 (CD11b/CD18). Journal of Immunology 156, 1235-1246. Trinchieri (1989). Biology of nature killer cells. Adaptive Immunol. 47, 187-376. Tripp, C. S., Wolf, S. F., and Unanue, E. R. (1993). Interleukin-12 and Tumor-necrosis-factor-alpha are costimulators of interferon-gamma production by natural-killer-cells in severe combined immunodeficiency mice with listeriosis, and interleukin-10 is a physiological antagonist. Proceedings of the National Academy of Sciences of the United States of America 90, 3725-3729. Tzianabos, A. O. (2000). Polysaccharide immunomodulators as therapeutic agents: Structural aspects and biologic function. Clinical Microbiology Reviews 13, 523-533. Vetvicka, V., and Yvin, J. C. (2004). Effects of marine beta-1,3 glucan on immune reactions. International Immunopharmacology 4, 721-730. Volman, J. J., Ramakers, J. D., and Plat, J. (2008). Dietary modulation of immune function by beta-glucans. Physiology & Behavior 94, 276-284. Wakshull, E., Brunke-Reese, D., Lindermuth, J., Fisette, L., Nathans, R. S., Crowley, J. J., Tufts, J. C., Zimmerman, J., Mackin, W., and Adams, D. S. (1999). PGG-Glucan, a soluble beta-(1,3)-glucan, enhances the oxidative burst response, microbicidal activity, and activates an NF-kappa B-like factor in human PMN: Evidence for a glycosphingolipid beta-(1,3)-glucan receptor. Immunopharmacology 41, 89-107. Wang, J., Wakeham, J., Harkness, R., and Xing, Z. (1999). Macrophages are a significant source of type 1 cytokines during mycobacterial infection. Journal of Clinical Investigation 103, 1023-1029. Warren, T. L., and Weiner, G. J. (2000). Uses of granulocyte-macrophage colony-stimulating factor in vaccine development. Current Opinion in Hematology 7, 168-173. Wasser, S. P. (2002). Medicinal mushrooms as a source of antitumor and immunomodulating polysaccharides. Application Microbiology Biotechnology 60, 258-274. Wasser, S. P., and Weis, A. L. (1999). Therapeutic effects of substances occurring in higher basidiomycetes mushrooms: A modern perspective. Critical Reviews in Immunology 19, 65-96. Yoon, T. J., Kim, J. Y., Kim, H., Hong, C., Lee, H., Lee, C. K., Lee, K. H., Hong, S., and Park, S. H. (2008a). Anti-tumor immunostimulatory effect of heat-killed tumor cells. Experimental and Molecular Medicine 40, 130-144. Yoon, T. J., Kim, T. J., Lee, H., Shin, K. S., Yun, Y. P., Moon, W. K., Kim, D. W., and Lee, K. H. (2008b). Anti-tumor metastatic activity of beta-glucan purified from mutated Saccharomyces cerevisiae. International Immunopharmacology 8, 36-42. Yuminamochi, E., Koike, T., Takeda, K., Horiuchi, I., and Okumura, K. (2007). Interleukin-12-and interferon-gamma-mediated natural killer cell activation by Agaricus blazei Murill. Immunology 121, 197-206. Zembala, M., Mytar, B., Popiela, T., and Asherson, G. L. (1977). Depressed invitro peripheral-blood lymphocyte-response to mitogens in cancer-patients - role of suppressor cells. International Journal of Cancer 19, 605-613. Zhong, M., Tai, A., and Yamamoto, I. (2005). In vitro augmentation of natural killer activity and interferon-gamma production in murine spleen cells with Agaricus blazei fruiting body fractions. Bioscience Biotechnology Biochemistery 69, 2466-2469. Zhu, J. K., Yu, G. Z., Liu, J. X., Pang, S. F., Lao, Z. G., and Tang, H. Y. (1987). Recent advances in microlymphatic surgery in China. Clinical Orthopaedics and Related Research, 32-39. | |
| dc.identifier.uri | http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/44547 | - |
| dc.description.abstract | 本實驗主要利用由裂褶菌中萃取出的裂褶多醣，以不同餵食頻率給予正常小鼠及擔癌小鼠，進而探討裂褶多醣對於小鼠的免疫調節及腫瘤抑制的效用。
首先取不同濃度裂褶多醣，0.1 ml餵食正常小鼠一次，隔天犧牲解剖並取出脾臟，實驗結果觀察到其中以餵食0.3 %裂褶多醣溶液，能夠有效提昇小鼠脾臟單核球細胞毒殺能力以及增生效率，因此在接下來的實驗當中，皆選用0.3 %裂褶多醣溶液餵食小鼠，並且搭配不同餵食頻率給予正常小鼠裂褶多醣一周，分別為每日給予、間隔一日給予、間隔兩日給予，並追蹤一周內免疫能力的變化。其中以每日餵食處理，於一周內能夠有效激活小鼠脾臟單核球細胞毒殺能力及增生活性效率較佳，兩天一次的處理，於一周內能夠有效提昇小鼠血清中細胞激素含量效率較好，顯示每日餵食及間隔一日餵食對於正常小鼠免疫能力提升效果較佳。 在小鼠的腫瘤抑制試驗中，分別使用每日餵食及間隔一日餵食的餵食頻率，於小鼠擔癌前七天開始餵食，連續餵食21天後犧牲小鼠並觀察其腫瘤大小與免疫調節能力。其中每日餵食組別抑制腫瘤增殖率較佳，並且檢測擔癌小鼠之脾臟單核球細胞毒殺能力、單核球細胞增生活性以及血清中細胞激素含量等免疫指標，發現有餵食多醣體皆能有效激活擔癌小鼠之各項免疫活性。 綜合以上結果我們可以發現，裂褶多醣能夠提升正常小鼠與擔癌小鼠的免疫活性及抗腫瘤能力，並且多醣的給予頻率確實會影響多醣體的免疫調節活性，其中以使用0.3 %的多醣濃度，搭配每日餵食的頻率，有較佳的免疫調節能力及腫瘤抑制率，因此認為每日給予小鼠0.3 %裂褶多醣為較適當的餵食頻率。 | zh_TW |
| dc.description.abstract | The present study aims to investigate Schizophyllan(SPG), a β-glucan polymer from Schizophyllum commune, efficacy on the activation of immune cells as well as antitumor activity on mice at various delivery frequency levels by oral route.
The results on the obserivation of efficacy of immune-enhancement in mice v.s Schizophyllan concentrations show that 0.3 % SPG solution in the optimal concentration for the experiment. It is therefore this concentration is used for the further study to investigate the most effective frequency for three groups of mice administrated with 0.3 % SPG at daily, two or three days interval in one week. The cytotoxicity, cell proliferation of splenic mononucleus cell and concentration of IL-12, IFN-γ in serum for the mice was observed. The results shows that daily administration of 0.3 % SPG for one week is superior then those received with the same dose by 2 days/once or 3 days/once on the enhancement of cytotoxicity activity and increases of splenic mononucleus cell proliferation of experiment mice. However, the highest IL-12 and IFN-γ in serum was observed in those mice received with Schizophyllan at 2 days/once group. In the obserivation of tumor supression, oral administration of Schizophyllan daily or 2 days/once at an experimental intervals, shows daily gave a better results. It is also shows that Schizophyllan signification enhanced cytotoxicity, cell proliferation and cytokine level than control. Considerind all these results, it suggested that oral Schizophyllan at 0.3 %, daily promoted better immunomodulation and antitumor activity. | en |
| dc.description.provenance | Made available in DSpace on 2021-06-15T03:04:20Z (GMT). No. of bitstreams: 1 ntu-98-R96b45012-1.pdf: 1529892 bytes, checksum: 30d742feb3db87157ffc788fae18b685 (MD5) Previous issue date: 2009 | en |
| dc.description.tableofcontents | 目錄……………………………………………….………………………I
圖表附件目錄……………………………………………………………II 中文摘要…………………………………………...…………………....IV 英文摘要………………………………………………………………...VI 第一章 前言……………………………………………………….…....1 第二章 文獻整理…………………………………………………….....3 第三章 材料方法……………………………………………………...20 第四章 結果…………………………………………………………...35 第五章 討論………………………………………………………..….43 參考文獻……………………………………………………….………..52 圖表附件………………………………………………………………...63 | |
| dc.language.iso | zh-TW | |
| dc.subject | 頻率 | zh_TW |
| dc.subject | 裂褶多醣 | zh_TW |
| dc.subject | 免疫調節 | zh_TW |
| dc.subject | 細胞毒殺 | zh_TW |
| dc.subject | 腫瘤 | zh_TW |
| dc.subject | Schizophyllan | en |
| dc.subject | frequency | en |
| dc.subject | tumor | en |
| dc.subject | cytotoxicity | en |
| dc.subject | Immunomodulation | en |
| dc.title | 口服裂褶多醣對免疫調節反應之影響 | zh_TW |
| dc.title | Immunomodulation of Oral Administration β-glucan Derived from Schizophyllum commune, Schizophyllan(SPG) | en |
| dc.type | Thesis | |
| dc.date.schoolyear | 97-2 | |
| dc.description.degree | 碩士 | |
| dc.contributor.oralexamcommittee | 王俊順,冉繁華 | |
| dc.subject.keyword | 裂褶多醣,免疫調節,細胞毒殺,腫瘤,頻率, | zh_TW |
| dc.subject.keyword | Schizophyllan,Immunomodulation,cytotoxicity,tumor,frequency, | en |
| dc.relation.page | 77 | |
| dc.rights.note | 有償授權 | |
| dc.date.accepted | 2009-07-30 | |
| dc.contributor.author-college | 生命科學院 | zh_TW |
| dc.contributor.author-dept | 漁業科學研究所 | zh_TW |
| 顯示於系所單位： | 漁業科學研究所 | |
文件中的檔案：
| 檔案 | 大小 | 格式 | |
|---|---|---|---|
| ntu-98-1.pdf 未授權公開取用 | 1.49 MB | Adobe PDF |
系統中的文件，除了特別指名其著作權條款之外，均受到著作權保護，並且保留所有的權利。